434 related articles for article (PubMed ID: 25184531)
1. Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states.
Fahrner JA; Bjornsson HT
Annu Rev Genomics Hum Genet; 2014; 15():269-93. PubMed ID: 25184531
[TBL] [Abstract][Full Text] [Related]
2. Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects.
Fahrner JA; Bjornsson HT
Hum Mol Genet; 2019 Nov; 28(R2):R254-R264. PubMed ID: 31595951
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics in the nervous system.
Jiang Y; Langley B; Lubin FD; Renthal W; Wood MA; Yasui DH; Kumar A; Nestler EJ; Akbarian S; Beckel-Mitchener AC
J Neurosci; 2008 Nov; 28(46):11753-9. PubMed ID: 19005036
[TBL] [Abstract][Full Text] [Related]
4. Developmental disorders with intellectual disability driven by chromatin dysregulation: Clinical overlaps and molecular mechanisms.
Larizza L; Finelli P
Clin Genet; 2019 Feb; 95(2):231-240. PubMed ID: 29672823
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction.
Sen N
Neuromolecular Med; 2015 Jun; 17(2):97-110. PubMed ID: 24777294
[TBL] [Abstract][Full Text] [Related]
6. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
8. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
[TBL] [Abstract][Full Text] [Related]
9. Histone acetylation: molecular mnemonics on the chromatin.
Gräff J; Tsai LH
Nat Rev Neurosci; 2013 Feb; 14(2):97-111. PubMed ID: 23324667
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.
Ciesielski O; Biesiekierska M; Balcerczyk A
Molecules; 2020 May; 25(10):. PubMed ID: 32429384
[TBL] [Abstract][Full Text] [Related]
12. Contribution of spurious transcription to intellectual disability disorders.
Scandaglia M; Barco A
J Med Genet; 2019 Aug; 56(8):491-498. PubMed ID: 30745423
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.
Maury E; Hashizume R
Epigenetics; 2017 May; 12(5):353-369. PubMed ID: 28059591
[TBL] [Abstract][Full Text] [Related]
14. Epigenome mapping highlights chromatin-mediated gene regulation in the protozoan parasite Trichomonas vaginalis.
Song MJ; Kim M; Choi Y; Yi MH; Kim J; Park SJ; Yong TS; Kim HP
Sci Rep; 2017 Mar; 7():45365. PubMed ID: 28345651
[TBL] [Abstract][Full Text] [Related]
15. Chromatin Structure and Dynamics: Focus on Neuronal Differentiation and Pathological Implication.
Nothof SA; Magdinier F; Van-Gils J
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456445
[TBL] [Abstract][Full Text] [Related]
16. [Epigenetics and etiology of neurodegenerative diseases].
Gruber BM
Postepy Hig Med Dosw (Online); 2011 Aug; 65():542-51. PubMed ID: 21918257
[TBL] [Abstract][Full Text] [Related]
17. DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling.
Savickiene J; Treigyte G; Jazdauskaite A; Borutinskaite VV; Navakauskiene R
Cell Biol Int; 2012 Nov; 36(11):1067-78. PubMed ID: 22845560
[TBL] [Abstract][Full Text] [Related]
18. Review-Epigenetic therapy for cancer.
Saleem M; Abbas K; Manan M; Ijaz H; Ahmed B; Ali M; Hanif M; Farooqi AA; Qadir MI
Pak J Pharm Sci; 2015 May; 28(3):1023-32. PubMed ID: 26004710
[TBL] [Abstract][Full Text] [Related]
19. Investigation of epigenetics in kidney cell biology.
Li LX; Agborbesong E; Zhang L; Li X
Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.
Ramakrishnan S; Pili R
Cancer J; 2013; 19(4):333-40. PubMed ID: 23867515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
